BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 32635979)

  • 1. Physcion 8-O-β-glucopyranoside exerts carcinostasis ability in Ishikawa cells via regulating lnc-SLC4A1-1/H3K27ac/NF-κB pathway.
    Yang L
    Pharmazie; 2020 Jul; 75(7):348-352. PubMed ID: 32635979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of lncRNA lnc-SLC4A1-1 induced by H3K27 acetylation promotes the development of breast cancer via activating CXCL8 and NF-kB pathway.
    Yi T; Zhou X; Sang K; Huang X; Zhou J; Ge L
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3765-3773. PubMed ID: 31556319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of NORAD/miR-608/STAT3 axis in carcinostasis effects of physcion 8-O-β-glucopyranoside on ovarian cancer cells.
    Yang X; Yan Y; Chen Y; Li J; Yang J
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2855-2865. PubMed ID: 31299866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physcion-8-O-β-d-glucoside interferes with the nuclear factor-κB pathway and downregulates P-glycoprotein expression to reduce paclitaxel resistance in ovarian cancer cells.
    Li X; He Y; Wei L; Zhang J; Li X; Cui W; Zhang S
    J Pharm Pharmacol; 2021 Mar; 73(4):545-552. PubMed ID: 33793827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The enhancer RNA lnc-SLC4A1-1 epigenetically regulates unexplained recurrent pregnancy loss (URPL) by activating CXCL8 and NF-kB pathway.
    Huang Z; Du G; Huang X; Han L; Han X; Xu B; Zhang Y; Yu M; Qin Y; Xia Y; Wang X; Lu C
    EBioMedicine; 2018 Dec; 38():162-170. PubMed ID: 30448228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physcion 8-O-β-glucopyranoside exhibits anti-growth and anti-metastatic activities in ovarian cancer by downregulating miR-25.
    Xue CL; Liu HG; Li BY; He SH; Yue QF
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5101-5112. PubMed ID: 31298363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RETRACTED: Physcion 8-O-β-glucopyranoside induces apoptosis, suppresses invasion and inhibits epithelial to mesenchymal transition of hepatocellular carcinoma HepG2 cells.
    Wang Q; Wang Y; Xing Y; Yan Y; Guo P; Zhuang J; Qin F; Zhang J
    Biomed Pharmacother; 2016 Oct; 83():372-380. PubMed ID: 27416558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physcion 8-O-β-glucopyranoside exhibits anti-leukemic activity through targeting sphingolipid rheostat.
    Han J; Zhao P; Shao W; Wang Z; Wang F; Sheng L
    Pharmacol Rep; 2018 Oct; 70(5):853-862. PubMed ID: 30092415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physcion 8-O-β-glucopyranoside induces mitochondria-dependent apoptosis of human oral squamous cell carcinoma cells via suppressing survivin expression.
    Liu MD; Xiong SJ; Tan F; Liu Y
    Acta Pharmacol Sin; 2016 May; 37(5):687-97. PubMed ID: 27063218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physcion 8-O-β-Glucopyranoside Exerts Anti-Tumor Activity Against Non-Small Cell Lung Cancer by Targeting PPARγ.
    Du Y; Lv Z; Sun D; Li Y; Sun L; Zhou J
    Anat Rec (Hoboken); 2019 May; 302(5):785-793. PubMed ID: 30312015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physcion 8-O-β-glucopyranoside suppresses the metastasis of breast cancer in vitro and in vivo by modulating DNMT1.
    Chen X; Guo H; Li F; Fan D
    Pharmacol Rep; 2017 Feb; 69(1):36-44. PubMed ID: 27768961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DJ-1 activates the noncanonical NF-κB pathway via interaction with Cezanne to inhibit the apoptosis and promote the proliferation of Ishikawa cells.
    Zhu QZ; Liu HY; Zhao XY; Qiu LJ; Zhou TT; Wang XY; Chen HP; Xiao ZQ
    Mol Biol Rep; 2021 Aug; 48(8):6075-6083. PubMed ID: 34374892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propofol inhibits proliferation, migration, and invasion but promotes apoptosis by regulation of Sox4 in endometrial cancer cells.
    Du Q; Liu J; Zhang X; Zhang X; Zhu H; Wei M; Wang S
    Braz J Med Biol Res; 2018; 51(4):e6803. PubMed ID: 29490000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lnc-NA inhibits proliferation and metastasis in endometrioid endometrial carcinoma through regulation of NR4A1.
    Sun L; Zhou R; Dong J; Liu S; Jiao Y; Wang L; Hu S; He P; Liu X; Zhao X; Jiang G; Zhao Y
    J Cell Mol Med; 2019 Jul; 23(7):4699-4710. PubMed ID: 31050196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposomal Curcumin Targeting Endometrial Cancer Through the NF-κB Pathway.
    Xu H; Gong Z; Zhou S; Yang S; Wang D; Chen X; Wu J; Liu L; Zhong S; Zhao J; Tang J
    Cell Physiol Biochem; 2018; 48(2):569-582. PubMed ID: 30021217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physcion 8-O-β-glucopyranoside prevents hypoxia-induced epithelial-mesenchymal transition in colorectal cancer HCT116 cells by modulating EMMPRIN.
    Ding Z; Xu F; Tang J; Li G; Jiang P; Tang Z; Wu H
    Neoplasma; 2016; 63(3):351-61. PubMed ID: 26925795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin inhibits proliferation and migration of endometrial cancer cells through regulating PI3K/AKT/MDM2 pathway.
    Qiang P; Shao Y; Sun YP; Zhang J; Chen LJ
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1778-1785. PubMed ID: 30840303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Estradiol enhances the proliferation and migration of Ishikawa cells by promotion of angiogenesis induced by activation of NF-κB via AKT pathway].
    Song H; Liang S; Zhang J; Li L
    Zhonghua Zhong Liu Za Zhi; 2014 Nov; 36(11):811-5. PubMed ID: 25620476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physcion and Physcion 8-O-β-D-glucopyranoside: Natural Anthraquinones with Potential Anticancer Activities.
    Adnan M; Rasul A; Hussain G; Shah MA; Sarfraz I; Nageen B; Riaz A; Khalid R; Asrar M; Selamoglu Z; Adem Ş; Sarker SD
    Curr Drug Targets; 2021; 22(5):488-504. PubMed ID: 33050858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel blocker of I kappa B alpha kinase that enhances cellular apoptosis and inhibits cellular invasion through suppression of NF-kappa B-regulated gene products.
    Ichikawa H; Takada Y; Murakami A; Aggarwal BB
    J Immunol; 2005 Jun; 174(11):7383-92. PubMed ID: 15905586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.